“The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica”

Patricia Moya Alvarado, Alejandro Fernandez Leon, Maria Emilia Corica, Valle Camacho Marti, Diego Alfonso López-Mora, Ivan Castellví Barranco, Hèctor Corominas
doi: https://doi.org/10.1101/2021.04.28.21256259

Article Information

doi 
https://doi.org/10.1101/2021.04.28.21256259
History 
  • April 30, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Patricia Moya Alvarado1,*,
  2. Alejandro Fernandez Leon2,
  3. Maria Emilia Corica3,
  4. Valle Camacho Marti2,
  5. Diego Alfonso López-Mora2,
  6. Ivan Castellví Barranco1 and
  7. Hèctor Corominas1
  1. 1Department of Rheumatology, Hospital Santa Creu i Sant Pau, Barcelona, Spain
  2. 2Department of Nuclear Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
  3. 3Department of Rheumatology, Hospital José N. Lencinas. Mendoza, Argentina
  1. ↵*Corresponding author E-mail: pmoyaa{at}santpau.cat (PMA)
Back to top
Posted April 30, 2021.
Download PDF
Data/Code
Email
“The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica”
Patricia Moya Alvarado, Alejandro Fernandez Leon, Maria Emilia Corica, Valle Camacho Marti, Diego Alfonso López-Mora, Ivan Castellví Barranco, Hèctor Corominas
medRxiv 2021.04.28.21256259; doi: https://doi.org/10.1101/2021.04.28.21256259
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area